KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Travere Therapeutics (TVTX) Receivables Refunds (2019 - 2021)

Historic Receivables Refunds for Travere Therapeutics (TVTX) over the last 3 years, with Q4 2021 value amounting to $247000.0.

  • Travere Therapeutics' Receivables Refunds fell 9855.91% to $247000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $247000.0, marking a year-over-year decrease of 9855.91%. This contributed to the annual value of $247000.0 for FY2021, which is 9855.91% down from last year.
  • According to the latest figures from Q4 2021, Travere Therapeutics' Receivables Refunds is $247000.0, which was down 9855.91% from $405000.0 recorded in Q3 2021.
  • Over the past 5 years, Travere Therapeutics' Receivables Refunds peaked at $20.2 million during Q1 2020, and registered a low of $247000.0 during Q4 2021.
  • Over the past 3 years, Travere Therapeutics' median Receivables Refunds value was $13.6 million (recorded in 2020), while the average stood at $10.1 million.
  • As far as peak fluctuations go, Travere Therapeutics' Receivables Refunds skyrocketed by 112881.72% in 2020, and later crashed by 9855.91% in 2021.
  • Quarter analysis of 3 years shows Travere Therapeutics' Receivables Refunds stood at $1.4 million in 2019, then surged by 1128.82% to $17.1 million in 2020, then tumbled by 98.56% to $247000.0 in 2021.
  • Its Receivables Refunds stands at $247000.0 for Q4 2021, versus $405000.0 for Q3 2021 and $400000.0 for Q2 2021.